site stats
First patient receives age-reversal therapy in historic human trialBoston-based Life Biosciences has dosed the first participant with ER-100, an experimental therapy designed to reverse aspects of cellular aging and treat vision loss
发布时间:
1
数据加载中
Markdown支持
评论加载中...
您可能感兴趣的: